MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze STE →
    • FindStock Picks / Stock Screener
    • Value · STEIntrinsic Value Calculator
    • Invest · STEInvestment Case
    • Hold · STE5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
STE stock logo

STE

STERIS plc

$255.75
0.99
 (0.39%)
Exchange:  NYSE
Market Cap:  24.835B
Shares Outstanding:  98.2M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – SpecialtiesView industry performance
   
CEO:  Daniel A. Carestio
Full Time Employees:  17937
Address: 
5960 Heisley Road
Mentor
OH
44060
US
Website:  https://www.steris.com
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

Click to read more…

Revenue Segmentation

Revenue by type

Revenue by region

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Log in — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
STSTE logoSTESTERIS plc24.8B30.325.18.8%
ALALC logoALCAlcon Inc.35.7B54.621.73.3%
MLMLAB logoMLABMesa Laboratories, Inc.719.0M10814.13.6%
QDQDEL logoQDELQuidelOrtho Corporation570.9M—12.4-2.4%
VVVVVV logoVVVVvVARDIS HOLDING AG Class A558.7M———
SISI logoSIShoulder Innovations, Inc.421.6M——-26.3%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/11/05 — 2 quarter 2027

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202420252026
Revenue5,138,7015,459,5155,935,900
Gross Profit2,218,1602,402,7642,626,500
EBITDA1,412,4051,358,6831,594,500
Operating Income836,118866,6411,101,800
Net Income378,239614,641785,100

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202420252026
Total Assets11,063,69710,146,81110,737,200
Total Liabilities4,748,3513,531,0543,540,000
Total Stockholders Equity6,302,1646,603,4057,197,200
Total Debt3,383,1672,202,540118,900
Cash and Cash Equivalents207,020171,701439,600

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202420252026
Operating Cash Flow973,2741,148,0871,341,400
Capital Expenditure-360,326-370,091-369,000
Free Cash Flow612,948777,996972,400
Net Income380,079616,074785,100
Net Change in Cash-1,337-35,319267,900

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)7,898,721.608Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)8,111,140.561Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)7,971,054.413Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)2,438,379.600Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)2,503,043.094Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)2,460,398.446Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)1,457,183.126Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)1,508,267.286Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)1,474,578.014Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)2,018,699.104Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)2,072,987.630Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)2,037,185.408Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)14.940Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)15.280Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)14.760Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)2Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
5.139B  ?P/S
 (TTM)
: 
4.03
?Net Income
 (TTM)
: 
378.239M  ?P/E
 (TTM)
: 
30.27
?Enterprise Value
 (TTM)
: 
26.355B  ?EV/FCF
 (TTM)
: 
28.13
?Dividend Yield
 (TTM)
: 
1.03%  ?Payout Ratio
 (TTM)
: 
30.49%
?ROE
 (TTM)
: 
11.48%  ?ROIC
 (TTM)
: 
8.81%
?Net Debt
 (TTM)
: 
2.165B  ?Debt/Equity
 (TTM)
: 
0.28
?P/B
 (TTM)
: 
3.43  ?Current Ratio
 (TTM)
: 
2.05

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
25.07Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates STE intrinsic value between $184.39 – $276.21 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate STE Intrinsic Value

Common questions about STE valuation

Is STERIS plc (STE) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for STERIS plc (STE) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is STE a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether STE trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is STE’s P/E ratio?

You can see STE’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for STE?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is STE a good long-term investment?

Whether STE fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for STERIS plc

  • STERIS plc intrinsic value calculatorEstimate what the business is worth
  • STERIS plc 5-year outlookWhat has to go right, and what could go wrong
STE

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

0.39
MarketSnap

Trading Metrics:

Open: 258.43   Previous Close: 254.76
Day Low: 254.99   Day High: 259.46
Year Low: 195.14   Year High: 269.44
Price Avg 50: 226.53   Price Avg 200: 224.04
Volume: 823416   Average Volume: 730385

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

STE Stock Up on Q2 Earnings & Revenue Beat, '27 EPS View Up
05-11-2026 09:56
STE Stock Up on Q2 Earnings & Revenue Beat, '27 EPS View Up
STERIS Announces Financial Results for Fiscal 2027 Second Quarter
04-11-2026 16:30
STERIS Announces Financial Results for Fiscal 2027 Second Quarter
STERIS Announces Dividend of $0.69 per share
28-10-2026 16:30
STERIS Announces Dividend of $0.69 per share
STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026
20-10-2026 16:30
STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026
Reasons to Add STE Stock to Your Portfolio Right Now
16-10-2026 09:15
Reasons to Add STE Stock to Your Portfolio Right Now
Steris to Acquire Xodus Medical for $2.1 Billion
12-10-2026 09:11
Steris to Acquire Xodus Medical for $2.1 Billion

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Pricing

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze STE →
    • FindStock Picks / Stock Screener
    • Value · STEIntrinsic Value Calculator
    • Invest · STEInvestment Case
    • Hold · STE5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Plans
    • Settings
    • Public profile ↗
  • Log in
  • Log out

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.